Torrent Pharmaceuticals has informed that the Board has considered and approved the change in Senior Management Personnel (SMP). The disclosure in respect of the change in SMP as prescribed under Listing Regulations read with SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023 is enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.